AxSpA

Largest, most representative Axial Spondyloarthritis data registry available for licensing, analytics, and collaboration

Research-Grade RWD in AxSpA

Unmet Need

Disease with no cure

With no cure for AxSpA, early diagnosis and effective treatment are the best ways to help reduce damaging effects and improve patients’ quality of life.

Deep Clinical Data

33,000+*

AxSpA patients followed prospectively with deep clinical, lab, and other linked data

*Counts complete through Q2 2023

Analytics & Modeling

342,900+*

AxSpA patients in the OM1 Real-World Data Cloud that can be used for modeling, analysis, and other research purposes

Why OM1 AxSpA?

 

Sample Use Cases

» Feasibility
» Comparative Effectiveness
» Passive Safety
» Natural History

 

Webinar: Real-World Data for R&D for Autoimmune & Chronic Diseases

Infosheet

Learn about the OM1 AxSpA Registry:

Request a Meeting

  • This field is for validation purposes and should be left unchanged.